Abstract
Cytokine release from irradiated cells has been postulated to start soon after irradiation preceding detectable clinical and pathological manifestation of lung injury. The expression of transforming growth factor beta (TGFβ), a fibrogenic and radiation-inducible cytokine, was studied from 1–16 weeks after the 15 and 30 Gray (Gy) of thoracic irradiation to rats. Thoracic irradiation caused an increase in TGFβ protein in bronchoalveolar lavage (BAL) fluid peaking at 3–6 weeks as compared to sham-irradiated control rats. Steady state TGFβ mRNA expression as shown by whole lung northern blot assay paralleled the TGFβ protein expression in BAL fluid. The peak of TGFβ protein increase in BAL fluid between 3 and 6 weeks coincided with the initial influx of inflammatory cells in BAL fluid, but preceded histologically discernable pulmonary fibrosis that was not apparent until 8–10 weeks after irradiation. In conclusion, TGFβ and mRNA and protein upregulation preceded the radiation-induced pulmonary fibrosis, suggesting a pathogenetic role in the development of radiation fibrosis.
Similar content being viewed by others
References
Rubin, P., L. S. Constine, andD. F. Nelson, 1992. Late effects of cancer treatment: radiation and drug toxicity.In C. A. Perez, and L. W. Brady, editors. Principles and practices of radiation oncology, 2nd ed. J. B. Lippincott, New York. 131–134.
Hallahan, D. E., A. Haimovitz-Friedman, D. W. Kufe, Z. Fuks, andR. R. Weichselbaum. 1993.In The role of cytokines in radiation oncology. Important advances in oncology, V. T. DeVita, S. Hellman, and S. A. Rosenberg, editors. J. B. Lippincott, New York. pp. 71–80.
Witte, L., Z. Fuks, A. Haimovitz-Friedman, I. Vlodavsky, D. S. Goodman, andA. Eldor. 1989. Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells.Cancer Res. 49:5066–5072.
Rubin, P., J. Finkelstein, andD. Shapiro. 1992. Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes. Interrelationship between the alveolar macrophages and the septal fibroblast.Int. J. Radiation Oncology Biol. Phys. 24:92–101.
Rosiello, R. A., W. W. Merrill, D. Rockwell, D. Carter, J. A. D. Cooper, S. Care, andE. P. Amento. 1993. Radiation pneumonitis. Bronchoalveolar lavage assessment and modulation by a recombinant cytokine.Am. Rev. Respir. Dis. 148:1671–1676.
Barcellos-Hoff, M. H., R. Derynck, M. L. S. Tsang, andJ. A. Weatherbee. 1994. Transforming growth factor beta activation in irradiation murine mammary gland.J. Clin. Invest. 93:892–899.
Anscher, M. S., T. Murase, D. M. Prescott, L. B. Marks, H. Reisenbichler, G. C. Bentel, D. Spencer, G. Sherouse, andR. L. Jirtle. 1994. Changes in plasma TGFbeta level during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis.Int. J. Radiation Oncology Biol. Phys. 30:671–676.
Finkelstein, J. N., C. J. Johnston, R. Baggs, andP. Rubin. 1994. Early alterations in extracellular matrix and transforming growth factor beta gene expression in mouse lung indicative of late radiation fibrosis.Int. J. Radiation Oncology Biol. Phys. 28:621–631.
Ulich, T. R., L. R. Watson, S. Yin, K. Guo, P. Wang, H. Thang, andJ. del Castillo. 1991. The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS- induced IL-1 and TNF and mRNA expression and the LPS-, IL-1, and TNF-induced inflammatory infiltrate.Am. J. Pathol. 138:1485–1496.
Danielpour, D., K. Y. Kim, L. L. Dart, S. Watanabe, A. B. Roberts, andM. B. Sporn. 1989. Sandwich enzyme-linked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGFβ1 and TGF-β2) in complex biological fluids.Growth Factors 2:61–71.
Chomczynski, P., andN. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction.Anal. Biochem. 162:156–159.
Qian, S. W., P. Kondaiah, A. B. Roberts, andM. B. Sporn. 1990. cDNA cloning by PCR of rat transforming growth factor beta-1.Nucleic Acids Res. 18:3059.
Hsu, S. M., L. Raine, andH. Fanger. 1981. The use of antiavidin antibody and anti-biotin-peroxidase complex in immunoperoxidase techniques.Am. J. Clin. Pathol. 75:816–821.
Phan, S. H., andS. L. Kunkel. 1992. Lung cytokine production in bleomycin-induced pulmonary fibrosis.Exp. Lung Research 18:29–43.
Kelley, J. 1993. Transforming growth factor beta.In Cytokines of the Lung, 1st ed., J. Kelley, editor. Marcel Dekker, New York. 101–137.
Raghow, R., P. Irish, andA. H. Kang. 1989. Coordinate regulation of transforming growth factor beta gene expression and cell proliferation in hamster lungs undergoing bleomycininduced pulmonary fibrosis.J. Clin. Invest. 84:1836–1842.
Breen, E., S. Shull, S. Burne, M. Absher, J. Kelley, S. Phan, andK. R. Cutroneo. 1992. Bleomycin regulation of transforming growth factor-beta mRNA in rat lung fibroblasts.Am. J. Res. Cell Mol. Biol. 6:146–152.
Khalil, N., R. N. O'Connor, K. C. Flanders, W. Shing, andC. I. Whitman. 1994. Regulation of type II alveolar epithelial cell proliferation by TGF-beta during bleomycin-induced lung injury in rats.Am. J. Physiol. 267:L498–507.
Giri, S. N., D. M. Hyde, andM. A. Hollinger. 1993. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice.Thorax 8:959–966.
Westergren-Thprsson, G., J. Hernnas, B. Sarnstrand, A. Oldberg, D. Heinegard, andA. Malmstrom. 1993. Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats.J. Clin. Invest. 92:632–637.
Hoyt, D. G., andJ. S. Lazo. 1990. Bleomycin and cyclophosphamide increase pulmonary type IV collagen mRNA in mice.Am. J. Physiol. 259:L47-L52.
Khalil, N., O. Bereznay, M. Sporn, andA. H. Greenberg. 1989. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary fibrosis.J. Exp. Med. 170:727–737.
Limper, A. H., T. J. Broekelmann, T. V. Colby, G. Malizia, andJ. A. McDonald. 1991. Analysis of local mRNA expression of extracellular matrix proteins and growth factors using in situ hybridization fibroproliferative lung disorders.Chest 99:55S-56S.
Khalil, N., R. N. O'Connor, H. W. Unruh, P. W. Warren, K. C. Flanders, A. Kemp, O. H. Bereznay, andA. H. Greenberg. 1991. Increased production and immunohistochemical localization of transforming growth factor beta in idiopathic pulmonary fibrosis.Am. J. Resp. Cell Mol. Biol. 5:155–162.
McDonald, S., P. Rubin, andP. Maasilta. 1989. Response of normal lung to irradiation. Tolerance doses/tolerance volumes in pulmonary radiation syndromes.In Radiation tolerance of normal tissues, J. M. Vaeth, and J. L. Meyer, editors. Karger, Basel. 255–276.
Veragara, J. A., U. Raymond, andL. A. Thet. 1986. Changes in lung morphology and cell number in radiation pneumonitis and fibrosis: A quantitative ultrastructural study.Int. J. Radiation Oncol. Biol. Phys. 13:723–732.
Rubin, P., S. McDonald, P. Maasilta, J. N. Finkelstein, D. L. Shapiro, D. Penney, andP. K. Gregory. 1989. Serum markers for production of pulmonary radiation syndromes. Part I: Surfactant apoprotein.Int. J. Radiation Oncol. Biol. Phys. 17:553–558.
Ulich, T. R., E. S. Yi, K. Longmuir, S. Yin, R. Blitz, C. Morris, R. M. Housley, andG. F. Pierce. 1994. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo.J. Clin. Invest. 93:1298–1306.
Deterding, R. R., T. Yano, A. M. Havill, C. R. Jacoby, J. M. Shannon, W. S. Simonet, andR. J. Mason. 1995. Keratinocyte growth factor prevents bleomycin lung injury in rats.Am. J. Resp. Crit. Care Med. 151:A198.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yi, E.S., Bedoya, A., Lee, H. et al. Radiation-induced lung injury in vivo: Expression of transforming growth factor—Beta precedes fibrosis. Inflammation 20, 339–352 (1996). https://doi.org/10.1007/BF01486737
Issue Date:
DOI: https://doi.org/10.1007/BF01486737